News and Insights | 10.21.2024
How Stocks Have Fared In The First Year Post-Election
Learn more
News and Insights | 10.18.2024
The ABC's of Biotechnology
Learn more
News and Insights | 10.18.2024
AI and US Equities: Growing into AI Phase 2 multiples and staying selective within AI Phase 3 stocks
Learn more
News and Insights | 09.04.2024
Gen AI: Too Much Spend, Too Little Benefit?
Learn more
News and Insights | 08.27.2024
SpirePoint Philanthropy Highlight - August
Learn more
News and Insights | 08.01.2024
SpirePoint Philanthropy Highlight - July
Learn more
News and Insights | 06.17.2024
The Modernization of Pathology-The Use of Artificial Intelligence within Digital Pathology
Learn more
News and Insights | 06.17.2024
Mid-Year Outlook: US Stocks and Economy
Learn more
News and Insights | 06.17.2024
SpirePoint Philanthropy Highlight-June
Learn more
News and Insights | 06.11.2024
SpirePoint Philanthropy Highlight-May
Learn more
News and Insights | 04.29.2024
AI: Generational Growth- AI, data centers and the coming US power demand surge
Learn more
News and Insights | 04.29.2024
Obesity: Top of Mind-Weighing the GLP-1 Market
Learn more
News and Insights | 04.29.2024
US Equity Views: 100 years of US equity market concentration and momentum
Learn more
News and Insights | 11.21.2023
GS Macro Outlook for 2024: Time for balance - modest returns, better diversification
Learn more
News and Insights | 11.15.2023
GS 2024 US Equity Outlook: “All You Had To Do Was Stay”
Learn more
News and Insights | 11.12.2023
GS 2024 US Economic Outlook: Final Descent (Mericle)
Learn more
News and Insights | 10.30.2023
US outperformance: at a turning point?
Learn more
News and Insights | 10.12.2023
Morgan Stanley Team with $1.9 Billion Goes Indie, Picks Goldman as Custodian
Learn more
News and Insights | 10.21.2024
How Stocks Have Fared In The First Year Post-Election
Learn more
News and Insights | 10.18.2024
AI and US Equities: Growing into AI Phase 2 multiples and staying selective within AI Phase 3 stocks
Learn more
News and Insights | 08.27.2024
SpirePoint Philanthropy Highlight - August
Learn more
News and Insights | 06.17.2024
The Modernization of Pathology-The Use of Artificial Intelligence within Digital Pathology
Learn more
News and Insights | 06.17.2024
SpirePoint Philanthropy Highlight-June
Learn more
News and Insights | 04.29.2024
AI: Generational Growth- AI, data centers and the coming US power demand surge
Learn more
News and Insights | 04.29.2024
US Equity Views: 100 years of US equity market concentration and momentum
Learn more
News and Insights | 11.15.2023
GS 2024 US Equity Outlook: “All You Had To Do Was Stay”
Learn more
News and Insights | 10.30.2023
US outperformance: at a turning point?
Learn more
News and Insights | 10.18.2024
The ABC's of Biotechnology
Learn more
News and Insights | 09.04.2024
Gen AI: Too Much Spend, Too Little Benefit?
Learn more
News and Insights | 08.01.2024
SpirePoint Philanthropy Highlight - July
Learn more
News and Insights | 06.17.2024
Mid-Year Outlook: US Stocks and Economy
Learn more
News and Insights | 06.11.2024
SpirePoint Philanthropy Highlight-May
Learn more
News and Insights | 04.29.2024
Obesity: Top of Mind-Weighing the GLP-1 Market
Learn more
News and Insights | 11.21.2023
GS Macro Outlook for 2024: Time for balance - modest returns, better diversification
Learn more
News and Insights | 11.12.2023
GS 2024 US Economic Outlook: Final Descent (Mericle)
Learn more
News and Insights | 10.12.2023
Morgan Stanley Team with $1.9 Billion Goes Indie, Picks Goldman as Custodian
Learn more
News and Insights | 10.21.2024
How Stocks Have Fared In The First Year Post-Election
Learn more
News and Insights | 10.18.2024
The ABC's of Biotechnology
Learn more
News and Insights | 10.18.2024
AI and US Equities: Growing into AI Phase 2 multiples and staying selective within AI Phase 3 stocks
Learn more
News and Insights | 09.04.2024
Gen AI: Too Much Spend, Too Little Benefit?
Learn more
News and Insights | 08.27.2024
SpirePoint Philanthropy Highlight - August
Learn more
News and Insights | 08.01.2024
SpirePoint Philanthropy Highlight - July
Learn more
News and Insights | 06.17.2024
The Modernization of Pathology-The Use of Artificial Intelligence within Digital Pathology
Learn more
News and Insights | 06.17.2024
Mid-Year Outlook: US Stocks and Economy
Learn more
News and Insights | 06.17.2024
SpirePoint Philanthropy Highlight-June
Learn more
News and Insights | 06.11.2024
SpirePoint Philanthropy Highlight-May
Learn more
News and Insights | 04.29.2024
AI: Generational Growth- AI, data centers and the coming US power demand surge
Learn more
News and Insights | 04.29.2024
Obesity: Top of Mind-Weighing the GLP-1 Market
Learn more
News and Insights | 04.29.2024
US Equity Views: 100 years of US equity market concentration and momentum
Learn more
News and Insights | 11.21.2023
GS Macro Outlook for 2024: Time for balance - modest returns, better diversification
Learn more
News and Insights | 11.15.2023
GS 2024 US Equity Outlook: “All You Had To Do Was Stay”
Learn more
News and Insights | 11.12.2023
GS 2024 US Economic Outlook: Final Descent (Mericle)
Learn more
News and Insights | 10.30.2023
US outperformance: at a turning point?
Learn more
News and Insights | 10.12.2023
Morgan Stanley Team with $1.9 Billion Goes Indie, Picks Goldman as Custodian
Learn more
Commentary | 10.21.2024
SpirePoint Quarterly Newsletter - October 2024
Learn more
Commentary | 10.04.2024
SpirePoint One-Year Anniversary
Learn more
Commentary | 08.27.2024
Having the Money Talk with Aging Parents
Learn more
Commentary | 07.31.2024
SpirePoint Quarterly Newsletter - July 2024
Learn more
Commentary | 10.21.2024
SpirePoint Quarterly Newsletter - October 2024
Learn more
Commentary | 10.04.2024
SpirePoint One-Year Anniversary
Learn more
Commentary | 08.27.2024
Having the Money Talk with Aging Parents
Learn more
Commentary | 07.31.2024
SpirePoint Quarterly Newsletter - July 2024
Learn more
News and Insights | 10.21.2024
How Stocks Have Fared In The First Year Post-Election
Learn more
Commentary | 10.21.2024
SpirePoint Quarterly Newsletter - October 2024
Learn more
News and Insights | 10.18.2024
The ABC's of Biotechnology
Learn more
News and Insights | 10.18.2024
AI and US Equities: Growing into AI Phase 2 multiples and staying selective within AI Phase 3 stocks
Learn more
Commentary | 10.04.2024
SpirePoint One-Year Anniversary
Learn more
News and Insights | 09.04.2024
Gen AI: Too Much Spend, Too Little Benefit?
Learn more
Commentary | 08.27.2024
Having the Money Talk with Aging Parents
Learn more
News and Insights | 08.27.2024
SpirePoint Philanthropy Highlight - August
Learn more
News and Insights | 08.01.2024
SpirePoint Philanthropy Highlight - July
Learn more
Media | 08.01.2024
Video
Welcome to SpirePoint Private Client
Learn more
Commentary | 07.31.2024
SpirePoint Quarterly Newsletter - July 2024
Learn more
News and Insights | 06.17.2024
The Modernization of Pathology-The Use of Artificial Intelligence within Digital Pathology
Learn more
News and Insights | 06.17.2024
Mid-Year Outlook: US Stocks and Economy
Learn more
News and Insights | 06.17.2024
SpirePoint Philanthropy Highlight-June
Learn more
News and Insights | 06.11.2024
SpirePoint Philanthropy Highlight-May
Learn more
Media | 06.11.2024
Video
Money Matters! Smart Financial Management for Women
Learn more
News and Insights | 04.29.2024
AI: Generational Growth- AI, data centers and the coming US power demand surge
Learn more
News and Insights | 04.29.2024
Obesity: Top of Mind-Weighing the GLP-1 Market
Learn more
News and Insights | 04.29.2024
US Equity Views: 100 years of US equity market concentration and momentum
Learn more
News and Insights | 11.21.2023
GS Macro Outlook for 2024: Time for balance - modest returns, better diversification
Learn more
News and Insights | 11.15.2023
GS 2024 US Equity Outlook: “All You Had To Do Was Stay”
Learn more
News and Insights | 11.12.2023
GS 2024 US Economic Outlook: Final Descent (Mericle)
Learn more
News and Insights | 10.30.2023
US outperformance: at a turning point?
Learn more
News and Insights | 10.12.2023
Morgan Stanley Team with $1.9 Billion Goes Indie, Picks Goldman as Custodian
Learn more
News and Insights | 10.21.2024
How Stocks Have Fared In The First Year Post-Election
Learn more
News and Insights | 10.18.2024
The ABC's of Biotechnology
Learn more
Commentary | 10.04.2024
SpirePoint One-Year Anniversary
Learn more
Commentary | 08.27.2024
Having the Money Talk with Aging Parents
Learn more
News and Insights | 08.01.2024
SpirePoint Philanthropy Highlight - July
Learn more
Commentary | 07.31.2024
SpirePoint Quarterly Newsletter - July 2024
Learn more
News and Insights | 06.17.2024
Mid-Year Outlook: US Stocks and Economy
Learn more
News and Insights | 06.11.2024
SpirePoint Philanthropy Highlight-May
Learn more
News and Insights | 04.29.2024
AI: Generational Growth- AI, data centers and the coming US power demand surge
Learn more
News and Insights | 04.29.2024
US Equity Views: 100 years of US equity market concentration and momentum
Learn more
News and Insights | 11.15.2023
GS 2024 US Equity Outlook: “All You Had To Do Was Stay”
Learn more
News and Insights | 10.30.2023
US outperformance: at a turning point?
Learn more
Commentary | 10.21.2024
SpirePoint Quarterly Newsletter - October 2024
Learn more
News and Insights | 10.18.2024
AI and US Equities: Growing into AI Phase 2 multiples and staying selective within AI Phase 3 stocks
Learn more
News and Insights | 09.04.2024
Gen AI: Too Much Spend, Too Little Benefit?
Learn more
News and Insights | 08.27.2024
SpirePoint Philanthropy Highlight - August
Learn more
Media | 08.01.2024
Video
Welcome to SpirePoint Private Client
Learn more
News and Insights | 06.17.2024
The Modernization of Pathology-The Use of Artificial Intelligence within Digital Pathology
Learn more
News and Insights | 06.17.2024
SpirePoint Philanthropy Highlight-June
Learn more
Media | 06.11.2024
Video
Money Matters! Smart Financial Management for Women
Learn more
News and Insights | 04.29.2024
Obesity: Top of Mind-Weighing the GLP-1 Market
Learn more
News and Insights | 11.21.2023
GS Macro Outlook for 2024: Time for balance - modest returns, better diversification
Learn more
News and Insights | 11.12.2023
GS 2024 US Economic Outlook: Final Descent (Mericle)
Learn more
News and Insights | 10.12.2023
Morgan Stanley Team with $1.9 Billion Goes Indie, Picks Goldman as Custodian
Learn more
News and Insights | 10.21.2024
How Stocks Have Fared In The First Year Post-Election
Learn more
Commentary | 10.21.2024
SpirePoint Quarterly Newsletter - October 2024
Learn more
News and Insights | 10.18.2024
The ABC's of Biotechnology
Learn more
News and Insights | 10.18.2024
AI and US Equities: Growing into AI Phase 2 multiples and staying selective within AI Phase 3 stocks
Learn more
Commentary | 10.04.2024
SpirePoint One-Year Anniversary
Learn more
News and Insights | 09.04.2024
Gen AI: Too Much Spend, Too Little Benefit?
Learn more
Commentary | 08.27.2024
Having the Money Talk with Aging Parents
Learn more
News and Insights | 08.27.2024
SpirePoint Philanthropy Highlight - August
Learn more
News and Insights | 08.01.2024
SpirePoint Philanthropy Highlight - July
Learn more
Media | 08.01.2024
Video
Welcome to SpirePoint Private Client
Learn more
Commentary | 07.31.2024
SpirePoint Quarterly Newsletter - July 2024
Learn more
News and Insights | 06.17.2024
The Modernization of Pathology-The Use of Artificial Intelligence within Digital Pathology
Learn more
News and Insights | 06.17.2024
Mid-Year Outlook: US Stocks and Economy
Learn more
News and Insights | 06.17.2024
SpirePoint Philanthropy Highlight-June
Learn more
News and Insights | 06.11.2024
SpirePoint Philanthropy Highlight-May
Learn more
Media | 06.11.2024
Video
Money Matters! Smart Financial Management for Women
Learn more
News and Insights | 04.29.2024
AI: Generational Growth- AI, data centers and the coming US power demand surge
Learn more
News and Insights | 04.29.2024
Obesity: Top of Mind-Weighing the GLP-1 Market
Learn more
News and Insights | 04.29.2024
US Equity Views: 100 years of US equity market concentration and momentum
Learn more
News and Insights | 11.21.2023
GS Macro Outlook for 2024: Time for balance - modest returns, better diversification
Learn more
News and Insights | 11.15.2023
GS 2024 US Equity Outlook: “All You Had To Do Was Stay”
Learn more
News and Insights | 11.12.2023
GS 2024 US Economic Outlook: Final Descent (Mericle)
Learn more
News and Insights | 10.30.2023
US outperformance: at a turning point?
Learn more
News and Insights | 10.12.2023
Morgan Stanley Team with $1.9 Billion Goes Indie, Picks Goldman as Custodian
Learn more